<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> is one of the most severe <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> that is mainly caused by either a Ser252Trp(S252W) or Pro253Arg(P253R) mutation in fibroblast growth factor receptor 2 (FGFR2) </plain></SENT>
<SENT sid="1" pm="."><plain>As an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder, <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> is mainly characterized by skull malformation resulting from premature fusion of craniofacial sutures, as well as <z:hpo ids='HP_0001159'>syndactyly</z:hpo>, etc </plain></SENT>
<SENT sid="2" pm="."><plain>A P253R mutation of FGFR2 results in nearly one-thirds of the cases of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> resulting from P253R mutation of FGFR2 is still not fully understood </plain></SENT>
<SENT sid="4" pm="."><plain>Here we reported a knock-in mouse model carrying P253R mutation in Fgfr2 </plain></SENT>
<SENT sid="5" pm="."><plain>The mutant mice exhibit smaller body size and <z:hpo ids='HP_0000248'>brachycephaly</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of the mutant skulls and long bones revealed premature fusion of coronal suture, shortened cranial base and growth plates of long bones </plain></SENT>
<SENT sid="7" pm="."><plain>In vitro organ culture studies further revealed that, compared with <z:mp ids='MP_0002169'>wild-type</z:mp> littermates, the mutant mice have prematurely fused coronal sutures and retarded long bone growth </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment of the cultured calvaria and femur with PD98059, an Erk1/2 inhibitor, resulted in partially alleviated coronal suture fusion and <z:hpo ids='HP_0001510'>growth retardation</z:hpo> of femur respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Our data indicated that the P253R mutation in Fgfr2 directly affect intramembranous and endochondral ossification, which resulted in the premature closure of coronal sutures and <z:hpo ids='HP_0001510'>growth retardation</z:hpo> of long bones and cranial base </plain></SENT>
<SENT sid="10" pm="."><plain>And the Erk1/2 signaling pathway partially mediated the effects of P253R mutation of Fgfr2 on cranial sutures and long bones </plain></SENT>
</text></document>